Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

EKSO
Ekso Bionics Holdings, Inc. Common Stock
stock NASDAQ

Inactive
May 4, 2026
11.80USD+0.085%(+0.01)100,566
Pre-market
0.00USD-100.000%(-11.79)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 21, 2022
04:01PM EST  Ekso Bionics Names Steven Sherman CEO; Scott Davis COO   Benzinga
04:01PM EST  Board Member Steven Sherman to be Appointed CEO   GlobeNewswire Inc
Jan 10, 2022
09:20AM EST  Ekso Bionics Sees Prelim. Q4 Sales $3.9M-$4.1M, Sees Prelim. FY21 Sales $11.1M-$11.3M   Benzinga
09:00AM EST  Company Achieves Record Quarterly Revenue of $3.9 million to $4.1 million1   GlobeNewswire Inc
Jan 4, 2022
08:30AM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022.   GlobeNewswire Inc
Dec 28, 2021
04:05PM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today announced the appointment of Corinna E. Lathan, Ph.D. to its Board of Directors, effective immediately.   GlobeNewswire Inc
Dec 16, 2021
04:16PM EST  Ekso Bionices Reports EksoNR Multi-Unit Order By Nebraska Fraternal Order Of Eagles, No Terms Disclosed   Benzinga
04:15PM EST  - Foundation Donates Units to Two Inpatient Rehabilitation Facilities in Nebraska -   GlobeNewswire Inc
Dec 3, 2021
03:45PM EST  EPO Site Shows Ekso Bionics, Inc. Granted European Patent Titled 'EXOSKELETON'   Benzinga
Nov 3, 2021
06:39AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 06.15 A.M. EDT).   RTTNews
Nov 2, 2021
05:54PM EDT  Ekso Bionics Holdings Q3 EPS $(0.17) Beats $(0.25) Estimate, Sales $3.00M Beat $2.58M Estimate   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
Oct 26, 2021
08:00AM EDT  Ekso Bionics to Report Third Quarter 2021 Financial Results on   GlobeNewswire Inc
Oct 19, 2021
01:53PM EDT  Ekso Bionics Receives Decision To Grant European Patent Titled 'MACHINE TO HUMAN INTERFACES FOR COMMUNICATION FROM A LOWER EXTREMITY ORTHOTIC'   Benzinga
Sep 7, 2021
04:04PM EDT  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will participate in a fireside chat at the H.C. Wainwright 23rd Annual Global Investor Conference held on September 13 - 15, 2021.   GlobeNewswire Inc
Aug 24, 2021
10:18AM EDT  Ekso Bionics Granted U.S. Patent Titled 'Human machine interfaces for lower extremity orthotics'   Benzinga
Aug 11, 2021
09:53AM EDT  Ekso Bionics Granted European Patent Titled 'POWERED ORTHOTIC SYSTEM FOR COOPERATIVE OVERGROUND REHABILITATION'   Benzinga
Jul 29, 2021
04:39PM EDT  Ekso Bionics Holdings Q2 EPS $(0.11) Beats $(0.25) Estimate, Sales $2.20M Beat $2.10M Estimate   Benzinga
04:23AM EDT  Earnings Scheduled For July 29, 2021   Benzinga
Jul 22, 2021
08:00AM EDT  Ekso Bionics to Report Second Quarter 2021 Financial Results on   GlobeNewswire Inc
May 11, 2021
04:40PM EDT  MedTech Round Up: Update On Products By Biomerica, 908 Devices, Ekso Bionics, Hologic   Benzinga
11:01AM EDT  Shares of Ekso Bionics Holdings Inc. (EKSO) are gaining over 11% on Tuesday morning after the exoskeleton producer announced an expanded partnership with Kindred Healthcare LLC.   RTTNews
08:10AM EDT  Ekso Bionics Announces EksoNR Will Be Available At Four Of Kindred's Long-Term Acute Care Hospitals In Florida   Benzinga
08:00AM EDT  Following Successful Pilot Program, EksoNR will be Available at Four of Kindreds Long-Term Acute Care Hospitals in Florida   GlobeNewswire Inc
Apr 29, 2021
05:06PM EDT  Ekso Bionics Holdings: Q1 Earnings Insights   Benzinga
04:27PM EDT  Ekso Bionics Holdings Q1 EPS $(0.34) Misses $(0.24) Estimate, Sales $1.90M Miss $3.00M Estimate   Benzinga
04:10AM EDT  Earnings Scheduled For April 29, 2021   Benzinga
Apr 22, 2021
08:00AM EDT  Ekso Bionics to Report First Quarter 2021 Financial Results on   GlobeNewswire Inc
Mar 9, 2021
09:17AM EST  Ekso Bionics Reports Partnership With US Physiatry To Educate Physicians On Clinical Benefits Of EksoNR Exoskeleton   Benzinga
08:00AM EST  Ekso Bionics Announces Partnership with U.S. Physiatry to Support   GlobeNewswire Inc
Mar 3, 2021
08:09AM EST  Ekso Bionics Teams Up with Performance Contracting, Inc. for Innovative Testing Approach of EVO Technology   Benzinga
08:00AM EST  Ekso Bionics Teams Up with Performance Contracting, Inc. for   GlobeNewswire Inc
Mar 2, 2021
08:00AM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright Global Life Sciences Conference held on March 9 10, 2021.   GlobeNewswire Inc
Feb 25, 2021
05:15PM EST  Recap: Ekso Bionics Holdings Q4 Earnings   Benzinga
04:57PM EST  Ekso Bionics Holdings Q4 EPS $(0.48) Misses $(0.30) Estimate, Sales $2.30M Miss $2.58M Estimate   Benzinga
04:03AM EST  Earnings Scheduled For February 25, 2021   Benzinga
Feb 24, 2021
10:22AM EST  Earnings Preview: Ekso Bionics Holdings   Benzinga
Feb 18, 2021
08:00AM EST  Ekso Bionics to Report Fourth Quarter and Full Year   GlobeNewswire Inc
Feb 12, 2021
10:22AM EST  AZ Fund 1 AZ Allocation Reports In 13G Filing A 5.086% Stake In Ekso Bionics Holdings   Benzinga
Feb 11, 2021
04:35PM EST  Ekso Bionics Announces Closing of $40 Million Bought Deal Offering   GlobeNewswire Inc
Feb 10, 2021
02:54AM EST  Today's Daily Dose brings you news about KalVista's hereditary angioedema trial results, Heat Biologics' encouraging data from its phase II trial of HS-110 in non-small cell lung cancer, Gamida's presentation of full efficacy and safety results of Omidubicel in patients with hematologic malignancies and Neovasc regaining Nasdaq compliance.   RTTNews
Feb 9, 2021
02:47PM EST  Mid-Afternoon Market Update: Dow Rises 50 Points; Heat Biologics Shares Spike Higher   Benzinga
12:27PM EST  Mid-Day Market Update: KalVista Pharmaceuticals Jumps Following Positive HAE Readout; Ekso Bionics Shares Slide   Benzinga
10:23AM EST  Mid-Morning Market Update: Markets Mixed; Bitcoin Hits Record High   Benzinga
08:43AM EST  Ekso Bionics Raises $40M From Upsized Equity Offering At 28% Discount, Shares Tank   Benzinga
Feb 8, 2021
11:30PM EST  Ekso Bionics Increases Previously Announced Bought Deal Offering   GlobeNewswire Inc
05:11PM EST  Ekso Bionics Reports $10M Bought-Deal Offering Of Common Stock   Benzinga
05:11PM EST  Ekso BionicsAnnounces $10 Million Bought Deal Offering   GlobeNewswire Inc
Jan 26, 2021
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
Jan 13, 2021
04:06PM EST  Ekso Bionics Sees Q4 Sales $2.3M vs $2.6M Estimate; FY20 Sales ~$8.9M vs $9M Est.   Benzinga
04:05PM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended December 31, 2020.   GlobeNewswire Inc
Jan 11, 2021
10:33AM EST  Shares of Ekso Bionics Holdings Inc. (EKSO) are gaining over 8% on Monday morning despite no-stock related news.   RTTNews
Jan 5, 2021
08:00AM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Peurach, President & Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will present at the H.C. Wainwright BioConnect 2021 Virtual Conference held January 11 14, 2021.   GlobeNewswire Inc
Dec 30, 2020
08:00AM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today announced the election of Mary Ann Cloyd and Rhonda A. Wallen to its Board of Directors by vote of stockholders at its 2020 Annual Meeting on December 29, 2020, effective immediately.   GlobeNewswire Inc
Dec 10, 2020
06:55AM EST  China Global Times Editor Tweeted: PLA troops stationed at an altitude of 5,000 meters in the Tibet area are now equipped with an exoskeleton suit, which can help them carry materials weighing as much as an adult and can effectively avoid waist/leg injuries.   Benzinga
Nov 10, 2020
08:09AM EST  Ekso Bionics Reports Subscription-Based Order By Cloverdale Foods   Benzinga
08:00AM EST  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the Company), an industry leader in exoskeleton technology for medical and industrial use, today announced the continued adoption of its latest industry exoskeleton innovation, EVO, with a subscription-based order by Cloverdale Foods Company, a fourth generation, family-owned meat company.   GlobeNewswire Inc
Oct 30, 2020
12:02PM EDT  Ekso Bionics shares are trading higher after the company reported better-than-expected Q3 EPS and sales results.   Benzinga
07:17AM EDT  HC Wainwright & Co. Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $11   Benzinga
Oct 29, 2020
04:50PM EDT  Ekso Bionics Holdings Q3 EPS $(0.01) Beats $(0.39) Estimate, Sales $2.90M Beat $2.45M Estimate   Benzinga
08:16AM EDT  Ekso Bionics Announces EGM Builders As First Customer To Adopt EVO Technology   Benzinga
08:00AM EDT  A cutting-edge endurance-boosting assistive device, EVO is designed to reduce the risk of repetitive or fatigue-related injuries for construction workers and other industrial employees   GlobeNewswire Inc
04:08AM EDT  Earnings Scheduled For October 29, 2020   Benzinga
Oct 22, 2020
08:00AM EDT  Ekso Bionics to Report Third Quarter 2020 Financial   GlobeNewswire Inc
Sep 9, 2020
08:00AM EDT  Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack Glenn, Chief Financial Officer of Ekso Bionics, will present at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference at 11:30 am ET / 8:30 am PT on Wednesday, September 16, 2020.   GlobeNewswire Inc
Aug 20, 2020
08:37AM EDT  Ekso Bionics Shares Spike; Co Unveils 'Latest Assistive Exoskeleton Innovation For Industrial Use'   Benzinga
08:30AM EDT  Ekso Bionics Unveils its Latest Assistive Exoskeleton   GlobeNewswire Inc
Aug 3, 2020
10:09AM EDT  Aegis Capital Maintains Buy on Ekso Bionics Holdings, Lowers Price Target to $9   Benzinga
Jul 30, 2020
04:31PM EDT  Ekso Bionics Holdings Q2 EPS $(1.88) May Not Compare To $(0.55) Estimate, Sales $2.30M Beat $1.62M Estimate   Benzinga
04:06AM EDT  Earnings Scheduled For July 30, 2020   Benzinga
Jul 23, 2020
08:00AM EDT  Ekso Bionics to Report Second Quarter 2020 Financial   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC